Susquehanna International Group, LLP 4 D Molecular Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 24,773 shares of FDMT stock, worth $218,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,773
Previous 34,023
27.19%
Holding current value
$218,745
Previous $714,000
62.61%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$65.2 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$45 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$43.2 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$38.9 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$36.2 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $286M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...